Corvus Pharmaceuticals, Inc. said it raised $69.0 million after issuing 8,117,647 shares of the company at $8.5 each, inclusive of the 1,058,823 shares granted to underwriters as part of their overallotment option.
Credit Suisse and Jefferies were acting as the joint book-running managers of the Burlingame, Calif.-based company's public offering.
Guggenheim Securities was acting as lead manager and Wedbush PacGrow was acting as co-manager.
